Cargando…
Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy
BACKGROUND: Trastuzumab (Herceptin), an antagonist to the human epidermal growth factor 2 (HER2) receptor significantly decreases the rates of breast cancer recurrence and mortality by 50%. Despite therapeutic benefits, the risk of cardiotoxicity with trastuzumab ranges from 10–15% when administered...
Autores principales: | Fallah-Rad, Nazanin, Lytwyn, Matthew, Fang, Tielan, Kirkpatrick, Iain, Jassal, Davinder S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2244612/ https://www.ncbi.nlm.nih.gov/pubmed/18272009 http://dx.doi.org/10.1186/1532-429X-10-5 |
Ejemplares similares
-
Acute severe mitral regurgitation: consideration of papillary muscle architecture
por: Czarnecki, Andrew, et al.
Publicado: (2008) -
Clinical utility of tissue Doppler imaging in patients with acute myocardial infarction complicated by cardiogenic shock
por: Hameed, Adnan K, et al.
Publicado: (2008) -
Vanishing left ventricular thrombus in a woman with peripartum cardiomyopathy: a case report
por: Altuwaijri, Wafa A, et al.
Publicado: (2012) -
Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
por: Strijack, Bradford, et al.
Publicado: (2008) -
Diffuse large B‐cell lymphoma mimicking cardiac amyloidosis
por: Lau, Lawrence, et al.
Publicado: (2017)